Medicina de Familia-SEMERGEN最新文献_第3页

Equidad y reticencia vacunal: más ética, por favor [公平与疫苗犹豫不决：请提供更多伦理信息]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102344

M. Cruz-Piqueras , J. Hortal-Carmona

引用次数: 0

Optimization of adherence to fixed-dose combination therapy in the treatment of cardiovascular risk factors in primary care 在初级保健中优化固定剂量联合疗法在心血管风险因素治疗中的依从性。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2025-01-01 DOI: 10.1016/j.semerg.2024.102337

F.J. Alonso Moreno , J. Espinosa García , F. López Simarro , L. Aliaga Gutiérrez , C. Montero Peña , A. Manzano Vilches , M. Ricote Belinchón , P. Panero Hidalgo , C. Escobar Cervantes

{"title":"Optimization of adherence to fixed-dose combination therapy in the treatment of cardiovascular risk factors in primary care","authors":"F.J. Alonso Moreno , J. Espinosa García , F. López Simarro , L. Aliaga Gutiérrez , C. Montero Peña , A. Manzano Vilches , M. Ricote Belinchón , P. Panero Hidalgo , C. Escobar Cervantes","doi":"10.1016/j.semerg.2024.102337","DOIUrl":"10.1016/j.semerg.2024.102337","url":null,"abstract":"<div><h3>Objective</h3><div>Provide consensus recommendations for the optimal management of fixed-dose combination therapies (FCT) in patients with cardiovascular risk factors (CVRF) in primary care (PC).</div></div><div><h3>Material and methods</h3><div>A modified Delphi technique was used. A scientific committee wrote 80 statements addressing controversial issues regarding adherence and the use of FCT in patients with CVRF. A panel of 52 PC specialists, experts in CVRF management and adherence evaluated the questionnaire in two rounds. The work was promoted by the Network of Experts in Adherence in Primary Care (REAAP).</div></div><div><h3>Results</h3><div>Agreement was reached on 66 of the 80 issues (82.5%). The panellists considered that the adherence of patients with CVRF treated in PC was inadequate, which could have clinical implications. The use of FCT might increase adherence compared to separate treatments. FCT usage promotion in PC was considered necessary, especially in polymedicated patients. Measures such as establishing specific protocols or improving the training of professionals in the FTC use are necessary. The FTC use was recommended as a reduction in long-term cardiovascular events in hypertension was observed, together with changes of the concept of high-intensity statins to high-intensity lipid-lowering therapy in dyslipidemia, or considering the use of FCT if the option was available in type 2 diabetes mellitus.</div></div><div><h3>Conclusions</h3><div>The expert consensus recommendations from this work may facilitate the use of FCT in patients with CVRF in PC.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 1","pages":"Article 102337"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142677757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Artificial intelligence for the comprehensive approach to orphan/rare diseases: A scoping review]. [人工智能用于孤儿/罕见病的综合方法：范围审查]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2024-12-28 DOI: 10.1016/j.semerg.2024.102434

L M Acero Ruge, D A Vásquez Lesmes, E H Hernández Rincón, L P Avella Pérez

{"title":"[Artificial intelligence for the comprehensive approach to orphan/rare diseases: A scoping review].","authors":"L M Acero Ruge, D A Vásquez Lesmes, E H Hernández Rincón, L P Avella Pérez","doi":"10.1016/j.semerg.2024.102434","DOIUrl":"https://doi.org/10.1016/j.semerg.2024.102434","url":null,"abstract":"<p><strong>Introduction: </strong>Orphan diseases (OD) are rare but collectively common, presenting challenges such as late diagnoses, disease progression, and limited therapeutic options. Recently, artificial intelligence (AI) has gained interest in the research of these diseases.</p><p><strong>Objective: </strong>To synthesize the available evidence on the use of AI in the comprehensive approach to orphan diseases.</p><p><strong>Methods: </strong>An exploratory systematic review of the Scoping Review type was conducted in PubMed, Bireme, and Scopus from 2019 to 2024.</p><p><strong>Results: </strong>fifty-six articles were identified, with 21.4% being experimental studies; 28 documents did not specify an OD, 8 documents focused primarily on genetic diseases; 53.57% focused on diagnosis, and 36 different algorithms were identified.</p><p><strong>Conclusions: </strong>The information found shows the development of AI algorithms in different clinical settings, confirming the potential benefits in diagnosis times, therapeutic options, and greater awareness among health professionals.</p>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 5","pages":"102434"},"PeriodicalIF":0.9,"publicationDate":"2024-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Mobile application development to improve the active search for functional impairment and persistent symptoms in individuals post-COVID-19. 移动应用程序开发，以改善对covid -19后个体功能障碍和持续症状的主动搜索。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2024-12-27 DOI: 10.1016/j.semerg.2024.102430

L M Serafim, R F Guimarães, L V Martins, G K F Freitas, F M G Liberato, G P de Morais Giglio, P H B Rizzi, H C Moreira, L A Martins, S C de Souza Cruz, V A da Silva, F M Paro

{"title":"Mobile application development to improve the active search for functional impairment and persistent symptoms in individuals post-COVID-19.","authors":"L M Serafim, R F Guimarães, L V Martins, G K F Freitas, F M G Liberato, G P de Morais Giglio, P H B Rizzi, H C Moreira, L A Martins, S C de Souza Cruz, V A da Silva, F M Paro","doi":"10.1016/j.semerg.2024.102430","DOIUrl":"https://doi.org/10.1016/j.semerg.2024.102430","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to develop a mobile application (App) to be used by primary care teams in the active search for functional impairment, long-term symptoms, and disabilities in individuals who have recovered from COVID-19, contributing to early treatment and referrals for multidisciplinary care and rehabilitation. This experimental study used the minimum viable product (MVP) methodology to develop an App named ReabilitaCOVID.</p><p><strong>Methods: </strong>This methodology involves ideation, content creation, prototype creation, usability tests, and adjustments based on feedback. The study was conducted in Brazil, and the population of the study included community health workers, who were the App's target users, and individuals from the community who had previously had COVID-19 and were at risk of developing PCS.</p><p><strong>Results: </strong>The App included a sociodemographic questionnaire, a clinical questionnaire, the post-COVID-19 Functional Status Scale (PCFS), the Modified Medical Research Council (MRC) Dyspnea Scale, and a flowchart. Usability tests were conducted, with feedback collected and adjustments made for improvements. Barriers to community health workers' use of the application were identified.</p><p><strong>Conclusion: </strong>A tailored app was developed for primary care teams to use in the active search for PCS. Functional and usability tests were performed in simulated and real environments. The App has the potential to facilitate referrals for multidisciplinary care and rehabilitation efficiently, and it will be available freely to public health care services. MVP is a suitable approach for developing a tailored App for healthcare teams.</p>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 4","pages":"102430"},"PeriodicalIF":0.9,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142900393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

El monstruo viene a verme [怪物来了]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2024-12-27 DOI: 10.1016/j.semerg.2024.102414

L. Fernández Segura

引用次数: 0

El tiempo es oro [时间的价值]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2024-12-27 DOI: 10.1016/j.semerg.2024.102412

L. Fernández Segura

引用次数: 0

«Dolor mixto»: conceptualización actual y aproximación para Atención Primaria [“混合性疼痛”：当前初级保健的概念和方法]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2024-12-27 DOI: 10.1016/j.semerg.2024.102447

A. Alcántara Montero

引用次数: 0

Ureterocele: hallazgo ecográfico poco común 输尿管囊肿：超声异常表现。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2024-12-24 DOI: 10.1016/j.semerg.2024.102436

I. Martín de la Sierra-Ruiz de Pascual , M. Sánchez-García , A.M. Gómez-Martín , M. Paños-Martínez , M.M. Alcázar-Martínez

引用次数: 0

[Hydration and natural mineral water: a review on the importance of water and mineral intake for health]. [水合作用和天然矿泉水：水和矿物质摄入对健康的重要性综述]。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2024-12-20 DOI: 10.1016/j.semerg.2024.102441

J M Fernández-García, O García-Vallejo, A M López-Sobaler, C Martín-Salinas, M González-Gross, R Urrialde

引用次数: 0

Head and neck cancer: An opportunity to review primary preventive care 头颈癌：回顾初级预防保健的机会。

IF 0.9

Medicina de Familia-SEMERGEN Pub Date : 2024-12-20 DOI: 10.1016/j.semerg.2024.102429

P. García-Regueras, R. Aispuru-Lanche

引用次数: 0